Pharmacokinetics of Rifampin and Isoniazid in Tuberculosis-HIVCoinfected Patients Receiving Nevirapine- or Efavirenz-Based Antiretroviral Treatment
Pharmacokinetics of Rifampin and Isoniazid in Tuberculosis-HIVCoinfected Patients Receiving Nevirapine- or Efavirenz-Based Antiretroviral Treatment
Antimicrob. agents chemother; 58 (6), 2014
This is a substudy of the Agence Nationale de Recherches sur le Sida et les Hépatites Virales (ANRS) Comparison of Nevirapine and Efavirenz for the Treatment of HIV-TB Co-infected Patients (ANRS 12146-CARINEMO) trial, which assessed the pharmacokinetics of rifampin or isoniazid with or without the coadm...
HIV/drug effects, Antitubercular Agents/administration & dosage, Benzoxazines, Mycobacterium, Mycobacterium tuberculosis/drug effects, Tuberculosis/drug therapy, Acquired Immunodeficiency Syndrome/epidemiology, HIV Seroprevalence/trends, Hepatitis/diagnosis, CD4 Antigens/drug effects, Mozambique/epidemiology